Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Mall
Gagan Deep
GD
Hake
Lori
L
Benjamin
Ashley B
AB
Adityanjee
A
A
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002389:Catatonia / Q000139:chemically induced*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone